| Literature DB >> 23374750 |
Jian Tian1,2, Daila S Gridley1, Sisi Tian3.
Abstract
BACKGROUND: Crew members on space missions inevitably are exposed to low background radiation and can receive much higher doses during solar particle events (SPE) that consist primarily of protons. Ionizing radiation could cause lung pathologies. Cell adhesion molecules (CAM) are believed to participate in fibrogenesis. Interactions between CAM and extracellular matrix (ECM) affect epithelial repair mechanisms in the lung. However, there are very limited data on biological effects of protons on normal lung tissue. Numerous reports have shown that exposure to low-dose/low-dose-rate (LDR) radiation can result in radioadaptation that renders cells more resistant to subsequent acute radiation. The goal of this study was to compare expression of genes associated with ECM and CAM, as well as critical profibrotic mediators, in mouse lungs after acute irradiation with photons and protons, and also determine whether pre-exposure to LDR γ-rays induces an adaptive effect.Entities:
Year: 2013 PMID: 23374750 PMCID: PMC3579759 DOI: 10.1186/1755-1536-6-4
Source DB: PubMed Journal: Fibrogenesis Tissue Repair ISSN: 1755-1536
Figure 1Photomicrographs of representative histopathological profiles. Sections of mouse lung tissue were paraffin-embedded post-irradiation and stained with hematoxylin and eosin in each cohort. Yellow arrows show fibrosis-like changes comprised of connective tissue and extracellular matrix present in samples from 0 Gy control and irradiated mice. B, bronchioles; V, vascular vessels. Magnification × 400, Bar = 20 μm.
Figure 2Masson trichrome staining of lung sections exhibits collagen deposition (blue). More abundant collagen is accumulated in alveolar space and at the sites surrounding vascular vessels or bronchioles in samples from Photon, Proton, LDR + Photon, and LDR + Proton groups as compared to the 0 Gy control and LDR samples. B, bronchioles; V, vascular vessels. Magnification × 400, Bar = 20 μm.
Symbols and description for all significantly modulated genes in irradiated groups compared to the 0 Gy control group
| | |
| CD44 antigen | |
| Cadherin 1 | |
| Cadherin 2 | |
| Connective tissue growth factor | |
| Fibronectin 1 | |
| Hyaluronan & proreoglycan link protein 1 | |
| Integrin alpha 2 | |
| Integrin alpha 3 | |
| Integrin alpha 4 | |
| Integrin alpha v | |
| Integrin alpha x | |
| Integriin beta 4 | |
| Neural cell adhesion molecule 1 | |
| Neural cell adhesion molecule 2 | |
| platelet/endothelial cell adhesion molecule 1 | |
| Selectin, endothelial cell | |
| Selectin, lymphocyte | |
| Selectin, platelet | |
| Transforming growth factor, beta induced | |
| | |
| A disintegrin & metallopeptidase with thrombospondin type I motif 1 | |
| A disintegrin & metallopeptidase with thrombospondin type I motif 5 | |
| Collagen, type I, alpha 1 | |
| Collagen, type IV, alpha 3 | |
| Collagen, type V, alpha 1 | |
| Laminin, alpha 2 | |
| Laminin, alpha 3 | |
| Laminin, beta 3 | |
| Laminin, gamma 1 | |
| Matrix metallopeptidase 2 | |
| Matrix metallopeptidase 7 | |
| Matrix metallopeptidase 8 | |
| Matrix metallopeptidase 11 | |
| Matrix metallopeptidase 13 | |
| Matrix metallopeptidase 14 | |
| Matrix metallopeptidase 15 | |
| Tissue inhibitor of metalloproteinase 1 | |
| Tissue inhibitor of metalloproteinase 3 | |
| Tenascin C |
Genes with ≥1.5-fold difference andP<0.05 compared to 0 Gy on day 21 and 56 post-irradiation
| - | - | −1.58 | - | - | |
| - | - | −2.49 | - | - | |
| - | 1.94 | - | 1.88 | 1.67 | |
| 1.82 | 2.40 | 2.28 | 2.52 | 1.58 | |
| - | - | - | 1.69 | 1.61 | |
| - | - | - | 1.81 | 1.60 | |
| - | - | - | 1.53 | - | |
| - | 1.96 | - | - | 1.87 | |
| - | 1.51 | - | 1.57 | - | |
| - | - | - | 1.61 | - | |
| - | 1.63 | - | 1.53 | 1.57 | |
| - | - | - | 1.53 | - | |
| 1.71 | - | - | - | - | |
| - | - | - | 1.77 | - | |
| - | 1.62 | - | - | 1.79 | |
| - | - | −1.62 | - | - | |
| −2.46 | - | - | - | - | |
| - | - | | - | 1.87 | |
| 1.61 | 1.63 | 1.62 | 1.94 | 1.59 | |
| 1.50 | 1.66 | 1.61 | 1.96 | 1.78 | |
| - | - | - | 2.11 | - | |
| - | - | - | 1.56 | 1.56 | |
| - | - | - | - | −1.50 | |
| 1.59 | 1.89 | - | - | - | |
| - | 2.44 | - | 1.98 | - | |
| - | 1.75 | - | 1.61 | - | |
| Total (26) | 6 | 11 | 6 | 16 | 12 |
| - | - | - | 1.57 | - | |
| - | - | - | 1.71 | - | |
| 2.97 | 4.02 | - | 3.98 | - | |
| - | 1.66 | - | - | - | |
| - | 1.67 | - | - | 2.31 | |
| 1.64 | - | - | 1.69 | - | |
| - | - | - | 1.70 | - | |
| 1.54 | 1.72 | - | - | - | |
| −1.63 | - | −1.82 | −1.52 | −2.09 | |
| - | 1.55 | - | - | - | |
| - | 1.86 | 1.74 | - | 1.71 | |
| - | - | - | 1.74 | - | |
| - | 1.58 | - | - | - | |
| - | 1.60 | - | - | - | |
| - | - | - | 1.76 | - | |
| - | - | - | - | −2.21 | |
| 1.55 | 1.75 | - | - | 1.66 | |
| 1.54 | 1.79 | - | - | 1.56 | |
| - | 1.94 | - | - | - | |
| 2.41 | - | - | 3.6 | - | |
| - | - | - | 3.46 | - | |
| - | - | 1.57 | - | - | |
| - | - | - | - | −1.94 | |
| - | 1.56 | - | - | - | |
| 3.70 | 4.00 | - | 4.10 | - | |
| - | 1.56 | - | - | - | |
| Total (26) | 8 | 14 | 3 | 11 | 7 |
Gene expression in lung samples was determined using quantitative RT-PCT. The numbers represents the fold-changes based on each irradiated group versus control group.
-, P value was >0.05 and/or relative fold-change was <1.5.
Genes with ≥1.5-fold andP<0.05 between irradiated groups on days 21 and 56 post-irradiation
| - | - | −1.52 | −1.6 | |
| −1.54 | - | - | - | |
| 1.86 | 1.56 | - | - | |
| 1.50 | - | - | 1.55 | |
| 2.04 | 2.91 | - | - | |
| 2.17 | 1.75 | −2.33 | - | |
| 1.94 | - | - | - | |
| Total (7) | 6 | 3 | 2 | 2 |
| - | 1.50 | - | - | |
| - | −1.51 | - | 2.52 | |
| - | 1.5 | - | - | |
| - | - | - | −1.64 | |
| - | - | - | −2.36 | |
| - | - | −1.97 | - | |
| - | - | - | −1.68 | |
| 2.09 | - | - | - | |
| Total (8) | 1 | 3 | 1 | 4 |
Gene expression in lung samples was determined using quantitative RT-PCT. The numbers represents the fold-changes based on each irradiated group versus control group.
-,P value was >0.05 and/or relative fold-change was <1.5.
Among 84 analyzed genes that were not affected by radiation exposure
| A disintegrin-like and metallopeptidease with thrombospondin type 1 motif, 2 | |
| A disintegrin-like and metallopeptidease with thrombospondin type 1 motif, 8 | |
| cadherin 1 | |
| cadherin 4 | |
| catenin (cadherin associated protein), alpha 1 | |
| catenin (cadherin associated protein), alpha 2 | |
| catenin (cadherin associated protein), beta 1 | |
| contactin 1 | |
| collagen, Type II, alpha 1 | |
| collagen, Type III, alpha 1 | |
| collagen, Type IV, alpha 1 | |
| collagen, Type IV, alpha 2 | |
| collagen, Type VI, alpha 1 | |
| extracellular matrix protein 1 | |
| elastin microfibril interfacer 1 | |
| Ectonucleoside triphosphate diphosphohydrolase 1 | |
| fibulin 1 | |
| hyaluronan and proteoglycan link protein 1 | |
| hemolytic complement | |
| intercellular adhesion molecule 1 | |
| integrin alpha 5 | |
| integrin alpha e | |
| integrin alpha l | |
| integrin alpha m | |
| integrin beta 1 | |
| integrin beta 2 | |
| integrin beta 3 | |
| integrin beta 4 | |
| laminin, alpha 1 | |
| laminin, beta 2 | |
| laminin, beta 3 | |
| matrix metallopeptidase 3 | |
| periostin, osteoblast specific factor | |
| secreted acidic cysteine rich glycoprotein | |
| secreted phosphoprotein 1 | |
| synaptotagmin 1 | |
| thrombospondin 1 | |
| thrombospondin 2 | |
| thrombospondin 3 | |
| Versican | |
| Vitronectin |
Figure 3Representative blots of four profibrotic mediators in lung tissue. Expression of the proteins (five samples/group) and β-actin was determined by Western blotting. The tables show the ratios of target bands to β-actin corresponding to western blots and analyzed with two-way ANOVA. *P <0.05 compared to 0 Gy at the corresponding time point; means +/− standard error of the means (SEM) are shown. LDR, low-dose/low-dose-rate.